Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension

Abstract Background This was a phase 3, randomized, double-blind, placebo-controlled study. Methods Adult Korean patients with essential hypertension and a baseline mean sitting clinic systolic blood pressure (scSBP) ≥150 and ≤180 mmHg were randomized to 6-week treatment with placebo (n = 65), azils...

Полное описание

Библиографические подробности

Главные авторы:	Attila Juhasz, Jingtao Wu, Michie Hisada, Tomoka Tsukada, Myung Ho Jeong
Формат:	Artigo
Язык:	Inglês
Опубликовано:	XMLink 2018-02-01
Серии:	Clinical Hypertension
Предметы:	Hypertension Azilsartan medoxomil Angiotensin II receptor antagonist Blood pressure Korea
Online-ссылка:	http://link.springer.com/article/10.1186/s40885-018-0086-4
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!